EX-FILING FEES 4 ex107.htm CALCULATION OF FILING FEE TABLES

 

Exhibit 107

 

Calculation of Filing Fee Tables

 

Form S-4

(Form Type)

 

IMAC Holdings, Inc.

(Exact Name of Registrant as Specified in its Charter)

 

Table 1: Newly Registered and Carry Forward Securities

 

  

Security

Type

 

Security

Class

Title

 

Fee

Calculation

or Carry

Forward

Rule

 

Amount

Registered

 

Proposed

Maximum

Offering

Price Per

Unit

 

Maximum

Aggregate

Offering

Price

   Fee Rate  

Amount of

Registration

Fee

 
Fees to Be
Paid
  Equity  Common stock, par value $0.001 per share  Rule 457(f)  6,450,672 (1)  N/A  $41,941,107.17(2)   0.00011020   $4,621.91 
   Total Offering Amounts   $4,621.91 
   Total Fees Previously Paid     
   Total Fee Offsets     
   Net Fee Due   $4,621.91 

 

(1) Relates to common stock, $0.001 par value per share, of IMAC Holdings, Inc., a Delaware corporation (“IMAC”), issuable to holders of common stock, $0.0001 par value per share, and holders of preferred stock, $0.0001 par value per share, of Theralink Technologies, Inc., a Nevada corporation (“Theralink”), in the proposed merger of (the “Merger”). The amount of IMAC common stock to be registered is based on the estimated number of shares of IMAC common stock that are expected to be issued (or reserved for issuance) pursuant to the Merger, assuming 1,138,354 shares of common stock of IMAC outstanding in a fully diluted basis and using the merger consideration calculation from the Merger Agreement resulting in current IMAC stockholders holding 15% of the issued and outstanding shares of common stock of IMAC following the Merger on a fully diluted basis.

 

(2) Estimated solely for the purpose of calculating the registration fee in accordance with Rule 457(c) under the Securities Act, based (x) on the average of the high and low prices of Theralink’s common stock reported on September 28, 2023 (such date being within five business days of the date that this registration statement was filed with the SEC), which is $0.0009, and (y) 46,601,230,184, the estimated maximum number of shares of Theralink common stock that may be exchanged or converted in the Merger described herein.